David H. Mack - Dec 15, 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
President and CEO, Director
Signature
/s/ David H. Mack
Stock symbol
PMVP
Transactions as of
Dec 15, 2021
Transactions value $
$4,770
Form type
4
Date filed
12/16/2021, 08:57 PM
Previous filing
Aug 20, 2021
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Gift $0 -40K -17.55% $0.00 188K Dec 9, 2021 See footnote F1
transaction PMVP Common Stock Gift $0 +40K $0.00 40K Dec 9, 2021 See footnote F2
transaction PMVP Common Stock Options Exercise $4.77K +9K +50.08% $0.53* 27K Dec 15, 2021 Direct
holding PMVP Common Stock 57K Dec 15, 2021 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Stock Option (right to buy) Options Exercise $0 -9K -2.04% $0.00 433K Dec 15, 2021 Common Stock 9K $0.53 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held of record by The Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F2 The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F3 The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F4 The shares subject to the option are fully vested and immediately exercisable.